Skip to main content

Day: May 22, 2020

AB “Rokiškio sūris” dividendų mokėjimo tvarka už 2019 m.

2020 m. balandžio 30 d. įvykęs AB „Rokiškio sūris“ (įmonės kodas 173057512, buveinės adresas Pramonės g.3, Rokiškis) eilinis visuotinis akcininkų susirinkimas už 2019 m. nusprendė paskirti 0,10 eurų dividendų vienai akcijai (bendra dividendams skiriama suma už 2019 m. sudaro 3,501 mln. eurų).Dividendus gaus tie asmenys, kurie dešimtos darbo dienos po sprendimą dėl dividendų mokėjimo priėmusio visuotinio akcininkų susirinkimo pabaigoje, t.y. 2020 m. gegužės 15 d.)  buvo AB ”Rokiškio sūris” akcininkai.Nuo 2020 m. gegužės 27 d. dividendai bus mokami tokia tvarka:akcininkams, kurių AB „Rokiškio sūris“ akcijų apskaita yra tvarkoma finansų maklerių įmonėse ar kredito įstaigų padaliniuose, teikiančiuose vertybinių popierių apskaitos paslaugas, dividendų suma, atskaičiavus gyventojų pajamų mokestį arba pelno mokestį pagal Lietuvos Respublikos...

Continue reading

Afya Limited Provides Business Update Relating to COVID-19 Outbreak

NOVA LIMA, Brazil, May 22, 2020 (GLOBE NEWSWIRE) — Afya Limited, or Afya (Nasdaq: AFYA), in order to provide shareholders and the market an update regarding the development of the ongoing COVID-19 pandemic and its impact on business, announces the following:As previously disclosed to the market on March 17, 2020, we managed to rapidly adapt our business to these unusual times, and although there has been an interruption of our on-campus activities, a significant portion of our non-practical educational activities are being successfully offered to our students through our online platform (rather than on-site) and we have received positive feedback from students, professors and physicians with respect to their digital experience.Regarding the offering of practical classes, we already resumed to provide in-hospital internships for...

Continue reading

Medtronic Guardian™ Connect Continuous Glucose Monitoring (CGM) System for Diabetes Now Compatible with Android Devices

DUBLIN, May 22, 2020 (GLOBE NEWSWIRE) — Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced U.S. Food and Drug Administration (FDA) approval for the Android™ version of its Guardian™ Connect continuous glucose monitoring (CGM) system. The Guardian Connect system is a standalone CGM system that alerts patients of potential high or low sensor glucose events up to 60 minutes in advance and provides confidence to people living with diabetes who worry about fluctuating glucose levels and dangerous low glucose events. The Guardian Connect app will include several enhancements to further improve user experience. These include easier product setup through the in-app Startup Wizard, and personalized volume adjustments, including the ability to mute alerts when individuals do not want to be disturbed for a period...

Continue reading

Urbanimmersive Announces Its 2020 Second Quarter Financial Results

LAVAL, Quebec, May 22, 2020 (GLOBE NEWSWIRE) — Urbanimmersive Inc. (“Urbanimmersive,” the “Company” or “UI”) (TSX VENTURE: UI) (OTC PINK: UBMRF) today announced select financial results and presents business highlights for the second quarter ended March 31, 2020. The interim consolidated financial statements and related management’s discussion and analysis (“MD&A”) can be viewed on SEDAR at https://www.sedar.com/.HIGHLIGHTSOn February 3rd, 2020, the Company completed a term loan financing of $1.45 million to be used primarily to repay the balance of the US denominated term loan of $1.07 million;On February 11, 2020, the Company launched a beta version of its new innovative product, the 3D Pocket WebsiteTM;On February 13, 2020, the Company completed the acquisition of Immersolution Inc., a reseller of 3D photographic equipment;For...

Continue reading

Urbanimmersive annonce les résultats financiers de son deuxième trimestre 2020

LAVAL, Québec, 22 mai 2020 (GLOBE NEWSWIRE) — Urbanimmersive inc. (« Urbanimmersive », la « Société » ou « UI ») (TSX CROISSANCE : UI) (OTC PINK : UBMRF) annonce aujourd’hui certains résultats financiers et présente les faits saillants des activités de son deuxième trimestre se terminant le 31 mars 2020. Les états financiers intérimaires consolidés et le rapport de gestion peuvent être consultés sur SEDAR à l’adresse https://www.sedar.com/.Faits saillants :Le 3 février 2020, la Société obtient un nouveau prêt à terme de 1,45 million $ servant principalement à rembourser en totalité le solde du prêt à terme libellé en $US de 1,07 million $;Le 11 février 2020, la Société lance une version bêta de son nouveau produit innovateur, le 3D Pocket WebsiteTM; Le 13 février 2020, la Société complète l’acquisition d’Immersolution Inc., un revendeur...

Continue reading

Verizon and NCMEC team up to fight child exploitation

Verizon donates over $1M in online advertising to help rescue missing childrenCampaign begins May 25 in support of National Missing Children’s DayNEW YORK, May 22, 2020 (GLOBE NEWSWIRE) — Verizon announced today a new partnership with the National Center for Missing & Exploited Children (NCMEC). In addition to being a corporate sponsor of NCMEC, Verizon will donate more than $1 million in online advertising on Verizon Media’s internet properties. The ads will seek the public’s assistance in bringing missing children home and will begin on May 25 in support of National Missing Children’s Day. As part of the launch, the Yahoo and AOL mail sign in pages, which are visited by millions of users every single day, will feature NCMEC ads exclusively.The new partnership is the latest chapter in Verizon’s long history of support for...

Continue reading

Medexus Provides an Update on the IXINITY® Acquisition and its Overall Business in the COVID-19 Environment

TORONTO and CHICAGO and MONTREAL, May 22, 2020 (GLOBE NEWSWIRE) — Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”) (TSX-V: MDP, OTCQB: PDDPF) today provided an update on its business in light of the recent transformative acquisition of the commercial hematology asset, IXINITY®, the resulting re-organization and alignment of Medexus’ U.S.-based business and the Company’s ongoing response to the COVID-19 pandemic.With the Company’s acquisition of Aptevo BioTherapeutics LLC (the “Acquisition”), which owns the IXINITY® asset, from Aptevo Therapeutics Inc. (“Aptevo”) having closed on February 28, 2020, the fiscal fourth quarter ending March 31, 2020 (“Q4 2020”) is the first quarter that includes revenue for Medexus from sales of IXINITY®. On May 13, 2020, Aptevo announced its financial results for its quarter ended March 31,...

Continue reading

Viomi Hosted 5G IoT Strategy & 2020 New Product Launch Event

GUANGZHOU, China, May 22, 2020 (GLOBE NEWSWIRE) — Viomi Technology Co., Ltd (“Viomi” or the “Company”) (NASDAQ: VIOT), a leading IoT @ Home technology company in China, hosted the Company’s 5G IoT Strategy and 2020 New Product Launch Event this week. The Company outlined its vision and product strategy for the imminent 5G + IoT era and reemphasized its long-term strategic objectives. A number of new and exciting product lines were introduced across the Company’s extensive product portfolio, including the state-of-the-art 21Face Interactive Smart Screen (TV).Viomi’s 21Face Interactive Smart Screen (TV) will come in four sizes, including a high-end 75-inch model with 5G connectivity and 8K resolution, delivering stunning, lifelike scenes. Equipped with industry-leading specifications, users will be able to enjoy next-generation content...

Continue reading

Syneos Health to Present at Upcoming Investor Conferences

MORRISVILLE, N.C., May 22, 2020 (GLOBE NEWSWIRE) — Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization combining a CRO (Contract Research Organization) and a CCO (Contract Commercial Organization), today announced that Chief Executive Officer Alistair Macdonald and Chief Financial Officer Jason Meggs are scheduled to present at two upcoming investor conferences:Jefferies Virtual Healthcare Conference on Wednesday, June 3, 2020, at 9:30 a.m. ET.William Blair 40th Annual Growth Stock Conference on Tuesday, June 9, 2020, at 9:00 a.m. ET.A live webcast of each event, along with a link to the presentation materials and archived audio replay of each presentation, will be available on the Company’s Investor Relations website at investor.syneoshealth.com.About Syneos HealthSyneos Health® (Nasdaq:SYNH)...

Continue reading

Norwood Financial Corp. Clarifies Web Address for Virtual Annual Meeting of Stockholders

HONESDALE, Pa., May 22, 2020 (GLOBE NEWSWIRE) — Norwood Financial Corp. (Nasdaq Global Market – NWFL) announced today a clarification of the web address for the Annual Meeting of Stockholders to be held over the internet in a virtual meeting format only on May 26, 2020, at 11:00 a.m. local time.  The virtual meeting will be hosted at www.meetingcenter.io/258232153. The password for the meeting is NWFL2020.  If you have previously voted, it is not necessary to vote at the meeting unless you wish to change your vote.  Previously, the web address included the prefix https://.  Norwood was recently advised that inclusion of such prefix in the web address has made it difficult to access the website.  For this reason, the Company suggests that stockholders wishing to attend the Annual Meeting use the web address shown above, which...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.